1491917-83-9 ((Sacituzumab govitecan)

Sacituzumab govitecan;hRS 7SN38;Sacituzumab govitecan [USAN];IMMU 132;Satralizumab linker;sacituzumab-govitecan;M9BYU8XDQ6;CYSTEINYL CL2A-SN-38;DTXSID401335985;hRS7-SN38;SN-38 CYSTEINYL CONJUGATE;IMMU-132;EX-A4354;DA64T2C2IO;1535963-91-7;DA-77702;GOVITECAN CYSTEINYL CONJUGATE;F82944;1796566-95-4;UNII-M9BYU8XDQ6;1491917-83-9;

ULRUOUDIQPERIJ-PQURJYPBSA-N

1S/C76H104N12O24S/c1-3-55-56-37-54(89)16-17-61(56)83-68-57(55)43-87-63(68)38-59-58(71(87)95)45-110-74(99)76(59,4-2)112-75(100)111-44-50-10-14-52(15-11-50)81-70(94)62(7-5-6-18-77)82-66(91)47-109-46-65(90)79-19-21-101-23-25-103-27-29-105-31-33-107-35-36-108-34-32-106-30-28-104-26-24-102-22-20-86-42-53(84-85-86)40-80-69(93)51-12-8-49(9-13-51)41-88-67(92)39-64(72(88)96)113-48-60(78)73(97)98/h10-11,14-17,37-38,42,49,51,60,62,64,89H,3-9,12-13,18-36,39-41,43-48,77-78H2,1-2H3,(H,79,90)(H,80,93)(H,81,94)(H,82,91)(H,97,98)/t49?,51?,60-,62-,64?,76-/m0/s1

S(C[C@@H](C(=O)O)N)C1CC(N(C1=O)CC1CCC(C(NCC2=CN(CCOCCOCCOCCOCCOCCOCCOCCOCCNC(COCC(N[C@H](C(NC3C=CC(=CC=3)COC(=O)O[C@@]3(C(=O)OCC4C(N5CC6=C(CC)C7C=C(C=CC=7N=C6C5=CC3=4)O)=O)CC)=O)CCCCN)=O)=O)N=N2)=O)CC1)=O